Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dov Freimark

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Transplantation|October 10, 2017
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-upYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2024
Comparison between invasive cardiac output and left ventricular assist device flow parameterAmitai Segev, Viana Copeland, Mateusz Sokolski, et al.
Clinical Transplantation|July 29, 2017
Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation RegistryMoshe Katz, Dov Freimark, Eugenia Raichlin, et al.
Heart Rhythm|September 18, 2017
CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalitiesRonen Ben Jehuda, Binyamin Eisen, Yuval Shemer, et al.
International Journal of Cardiology|June 14, 2020
Reduction in Filamin C transcript is associated with arrhythmogenic cardiomyopathy in Ashkenazi JewsShimrit Oz, Hagith Yonath, Leonid Visochyk, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
International Journal of Cardiology|December 10, 2013
Titin mutation in familial restrictive cardiomyopathyYael Peled, Michael Gramlich, Guy Yoskovitz, et al.
BMC Medicine|May 2, 2017
Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trialOfra Kalter-Leibovici, Dov Freimark, Laurence S Freedman, et al.
Heart (British Cardiac Society)|May 4, 2015
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chainDiego García-Giustiniani, Michael Arad, Martín Ortíz-Genga, et al.
Plos One|October 18, 2018
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathyRevital Schick, Lucy N Mekies, Yuval Shemer, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Transplantation|October 10, 2017
Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-upYael Peled, Jacob Lavee, Eugenia Raichlin, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2024
Comparison between invasive cardiac output and left ventricular assist device flow parameterAmitai Segev, Viana Copeland, Mateusz Sokolski, et al.
Clinical Transplantation|July 29, 2017
Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation RegistryMoshe Katz, Dov Freimark, Eugenia Raichlin, et al.
Heart Rhythm|September 18, 2017
CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalitiesRonen Ben Jehuda, Binyamin Eisen, Yuval Shemer, et al.
International Journal of Cardiology|June 14, 2020
Reduction in Filamin C transcript is associated with arrhythmogenic cardiomyopathy in Ashkenazi JewsShimrit Oz, Hagith Yonath, Leonid Visochyk, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
International Journal of Cardiology|December 10, 2013
Titin mutation in familial restrictive cardiomyopathyYael Peled, Michael Gramlich, Guy Yoskovitz, et al.
BMC Medicine|May 2, 2017
Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trialOfra Kalter-Leibovici, Dov Freimark, Laurence S Freedman, et al.
Heart (British Cardiac Society)|May 4, 2015
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chainDiego García-Giustiniani, Michael Arad, Martín Ortíz-Genga, et al.
Plos One|October 18, 2018
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathyRevital Schick, Lucy N Mekies, Yuval Shemer, et al.
Pageof 9